Gene · 10332
Papers1,514
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,514
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emergence of SARS-CoV-2 omicron variant JN.1 in Tamil Nadu, India - Clinical characteristics and novel mutations. | Sci Rep | 2024 | 39080396 | PubTator, text mining | PubMed |
| Probing scaffold size effects on multivalent lectin-glycan binding affinity, thermodynamics and antiviral properties using polyvalent glycan-gold nanoparticles. | Nanoscale | 2024 | 38984502 | PubTator, text mining | PubMed |
| A novel efficient strategy to generate liver sinusoidal endothelial cells from human pluripotent stem cells. | Sci Rep | 2024 | 38879647 | PubTator, text mining | PubMed |
| Relationship between the Number of Repeats in the Neck Regions of L-SIGN and Augmented Virus Replication and Immune Responses in Dengue Hemorrhagic Fever. | Int J Mol Sci | 2024 | 38791534 | PubTator, text mining | PubMed |
| Evolving roles of glycosylation in the tug-of-war between virus and host. | Natl Sci Rev | 2024 | 38784919 | PubTator, text mining | PubMed |
| Probing the pH-dependency of DC-SIGN/R multivalent lectin-glycan interactions using polyvalent glycan-gold nanoparticles. | Nanoscale Adv | 2024 | 38633047 | PubTator, text mining | PubMed |
| Identification and Analysis of Gene Biomarkers for Ovarian Cancer. | Genet Test Mol Biomarkers | 2024 | 38416665 | PubTator, text mining | PubMed |
| Correspondence on Editorial regarding "Identification of signature gene set as highly accurate determination of MASLD progression". | Clin Mol Hepatol | 2024 | 38390704 | PubTator, text mining | PubMed |
| Identification of integrated proteomics and transcriptomics signature of alcohol-associated liver disease using machine learning. | PLOS Digit Health | 2024 | 38335183 | PubTator, text mining | PubMed |
| A genetic association study of circulating coagulation factor VIII and von Willebrand factor levels. | Blood | 2024 | 38320121 | PubTator, text mining | PubMed |
| Binding affinity between coronavirus spike protein and human ACE2 receptor. | Comput Struct Biotechnol J | 2024 | 38304547 | PubTator, text mining | PubMed |
| Glucosylceramide in bunyavirus particles is essential for virus binding to host cells. | Cell Mol Life Sci | 2024 | 38300320 | PubTator, text mining | PubMed |
| Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissue. | Nat Commun | 2024 | 38291024 | PubTator, text mining | PubMed |
| Myocardial Oedema as a Consequence of Viral Infection and Persistence-A Narrative Review with Focus on COVID-19 and Post COVID Sequelae. | Viruses | 2024 | 38257821 | PubTator, text mining | PubMed |
| SARS-CoV-2 ORF3a Protein as a Therapeutic Target against COVID-19 and Long-Term Post-Infection Effects. | Pathogens | 2024 | 38251382 | PubTator, text mining | PubMed |
| Navigating the Complex Landscape of Ebola Infection Treatment: A Review of Emerging Pharmacological Approaches. | Infect Dis Ther | 2024 | 38240994 | PubTator, text mining | PubMed |
| SARS-CoV-2 immunity in animal models. | Cell Mol Immunol | 2024 | 38238440 | PubTator, text mining | PubMed |
| CD301 and LSECtin glycan-binding receptors of innate immune cells serve as prognostic markers and potential predictors of immune response in breast cancer subtypes. | Glycobiology | 2024 | 38206856 | PubTator, text mining | PubMed |
| Cellular zinc metabolism and zinc signaling: from biological functions to diseases and therapeutic targets. | Signal Transduct Target Ther | 2024 | 38169461 | PubTator, text mining | PubMed |
| SARS-CoV-2 receptor ACE2 is upregulated by fatty acids in human MASH. | JHEP Rep | 2024 | 38074511 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10332/papers?page=3